Table 2.
Baseline Characteristics for the Liver Cases and their matched Controls.
| Baseline Characteristics | Case (n = 13) | Control (n = 25) |
|---|---|---|
| Age ± SD (years) | 48.69 ± 9.48 | 46.88 ± 8.07 |
| Mean baseline CD4 + T cell count (cells/µl) ± SD | 487.9 ± 156.8 | 582.6 ± 243.2 |
| Mean nadir CD4 + T cell count (cells/µl) ± SDa | 155.6 ± 109.0 | 278.2 ± 278.2 |
| Mean BMI (kg/m2) ± SD | 22.08 ± 4.32 | 23.52 ± 3.31 |
| Mean hs-CRP (mg/L) ± SDa | 9.95 ± 17.98 | 2.58 ± 4.01 |
| D-dimer (µg/mL) | 0.43 ± 0.32 | 0.37 ± 0.27 |
| IL-6 (pg/mL)a | 3.71 ± 1.92 | 2.27 ± 1.39 |
| Time to deathb (days) | 1022 ± 660.9 | 2080 ± 585.3 |
| Gender - no. (%) male | 11 (85) | 21 (84) |
| Race - no. (%) white | 9 (70) | 16 (64) |
| Race - no. (%) black | 1 (7) | 2 (8) |
| Race - no. (%) other/unknown | 3 (23) | 7 (28) |
| HBV - no. (%) surface antigen positive | 2 (15) | 0 (0) |
| HCV - no. (%) antibody positive | 4 (31) | 5 (20) |
| Previous AIDS - no. (%) | 3 (23) | 8 (28) |
| Diabetes - no. (%) baseline positive | 1 (7) | 2 (8) |
| CVD - no. (%) baseline positive | 0 (0) | 0 (0) |
| Lipid - Lowering Drug no. (%) baseline positive) | 2 (15) | 3 (12) |
| Blood Pressure Lowering Drug - no. (%) baseline positive | 2 (15) | 1 (4) |
aSignificantly different between cases and controls, as measured by Mann-Whitney U test.
bTime to death is days from randomization to death for the cases and days from randomization to censoring for the controls.